1Soriano R.Renal tubular acidosis:the clinical entity[J].J Am Soc Nephrol,2002,13(8):2160-2170.
2Lim S.Metabolic acidosis[J].Acta Med Indones,2007,39(3):145-150.
3Hulter HN,Ilnicki LP,Harbottle JA,et al.Impaired renal H+secretion and NH3 production in mineralocorticoid-deficientglucocorticoid-replete dogs[J].Am J Physio,1977,232(2):F136-F146.
4Karet FE.Mechanisms in hyperkalemic renal tubular acidosis[J].J Am Soc Nephrol,2009,20(2):251-254.
5Hrnciar J.Diabetic nephropathy and isolated hyporeninemic hypoaldosteronism[J].Vnitr Lek,1996,42(6):394-399.
7Caravaca F,Arrobas M,Pizarro JL,et al.Metabolic acidosis in advanced renal failure:differences between diabetic and nondiabetic patients[J].Am J kidney Dis,1999,33(5):892-898.
8Sabatini S,Kurtzman NA.Bicarbonate therapy in severe metabolic acidosis[J].J Am Soc Nephrol,2009,20(4):692-695.
二级参考文献5
1Shayakul C,Jarolim P,Zachlederova M,et al.Characterization of a highly polymorphic marker adjacent to the SLC4A1 gene and of kidney immunostaining in a family with distal renal tubular acidosis[J].Nephrol Dial Transplant,2004; 19 (2):371-9.
2Gregory MJ,Schwartz GJ.Diagnosis and treatment of tubular disorders[J].Semin Nephrol,1998 ;18(3):317.
3Rodriguez Soriano.Renal tubular acidosis:the clinical entity[J].J Am Soc Nephrol,2002;13(8):2160-70.
4Kourambas J,Aslan P,The C,et al.Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis[J].J Endourol,2001;15(2):181-6.